SCHEMBL4032042

SCHEMBL4032042

Cn1c(-c2cccs2)nc(C(=O)O)c(O)c1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ERCC1 P07992 5/20 1.00
FEN1 P39748 5/20 1.00
ERCC4 Q92889 5/20 1.00
KDM4E B2RXH2 6/20 0.46
ALDH1A1 P00352 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
HPGD P15428 3/20 0.45
POLB P06746 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44
LMNA P02545 2/20 0.42
MEN1 O00255 1/20 0.42
PLA2G1B P04054 1/20 0.42
KMT2A Q03164 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ATG4B Q9Y4P1 1/20 0.42
DNASE1 P24855 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4025290 0.83 ERCC1 (0.71) ERCC1FEN1ERCC4KDM4EALDH1A1
SCHEMBL4032043 0.81 ERCC1 (0.67) ERCC1FEN1ERCC4KDM4EALDH1A1
SCHEMBL4028669 0.79 FEN1 (0.65) ERCC1FEN1ERCC4KDM4EALDH1A1
SCHEMBL4029715 0.78 ERCC1 (0.63) ERCC1FEN1ERCC4KDM4EALDH1A1
SCHEMBL4029253 0.77 FEN1 (0.63) ERCC1FEN1ERCC4KDM4EALDH1A1
SCHEMBL4027678 0.76 FEN1 (0.62) ERCC1FEN1ERCC4NPC1RAB9A
SCHEMBL6436946 0.76 FEN1 (0.62) ERCC1FEN1ERCC4
SCHEMBL4025971 0.76 FEN1 (0.61) ERCC1FEN1ERCC4KDM4EALDH1A1
SCHEMBL4026398 0.76 ERCC1 (0.61) ERCC1FEN1ERCC4KDM4E
Hydrochloric Acid SCHEMBL4031283 0.75 FEN1 (0.60) ERCC1FEN1ERCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1470113-B1 PYRIMIDINONE VIRAL POLYMERASE INHIBITORS ANGELETTI P IST RICHERCHE BIO (IT) 2009-01-07 EP claimed
US-20050130997-A1 Pyrimidinone viral polymerase inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2005-06-16 US claimed
EP-1470113-B1 PYRIMIDINONE VIRAL POLYMERASE INHIBITORS ANGELETTI P IST RICHERCHE BIO (IT) 2009-01-07 EP disclosed
US-20050130997-A1 Pyrimidinone viral polymerase inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2005-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050130997-A1 Pyrimidinone viral polymerase inhibitors POLR2A, POLR1E, POLR2E ERCC1 3181/4885FEN1 343/4885ERCC4 1663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.